Clarivate Analytics plc (NYSE:CCC; CCC.WS) (“Clarivate”), a global leader in providing trusted insights and analytics to accelerate the pace of innovation, today announced it has completed its acquisition of Decision Resources Group (“DRG”). Previously, Clarivate announced on January 17, 2020 its intent to acquire DRG from Piramal Enterprises Limited (“PEL”, NSE: PEL, BSE: 500302), part of global business conglomerate Piramal Group.
“We are excited to welcome DRG’s colleagues to Clarivate and begin to roll out the many benefits of this acquisition to customers and colleagues alike,” said Jerre Stead, Executive Chairman and CEO of Clarivate. “People are our only sustainable competitive advantage and both organizations are built on amazing people with deep industry, subject matter and technical expertise. We will move quickly and smoothly to integrate DRG with our Science Group. For customers, the combination of DRG’s services and solutions with Clarivate’s Life Sciences solutions, including CortellisTM, will help customers make smarter, faster evidence-based decisions to boost clinical and commercial success.”
DRG is a premier provider of high-value data, analytics and insights products and services to the healthcare industry. DRG specializes in enabling the world’s leading pharma, biotech and medical technology companies to achieve commercial success in complex health markets with the creation of effective patient-centric commercial strategies.
